 | • レポートコード：GIR-2104Z07921 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、鉄欠乏性貧血治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。鉄欠乏性貧血治療薬の種類別市場規模（処方薬、市販薬（OTC））、用途別市場規模（子供、大人、高齢者）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・鉄欠乏性貧血治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AMAG Pharmaceuticals, Inc、Meda Consumer Healthcare Inc、American Regent, Inc、GSK、Avion Pharmaceuticals, LLC、Bausch Health Companies Inc、Colorado BiolabsInc、Prestige Consumer Healthcare Inc、Keryx Biopharmaceuticals, Inc、Daiichi Sankyo, Inc.、DSE Healthcare Solutions, LLC ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：処方薬、市販薬（OTC） ・用途別分析2016年-2026年：子供、大人、高齢者 ・鉄欠乏性貧血治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・鉄欠乏性貧血治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・鉄欠乏性貧血治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・鉄欠乏性貧血治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・鉄欠乏性貧血治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Iron Deficiency Anemia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Iron Deficiency Anemia Drug size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Iron Deficiency Anemia Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Iron Deficiency Anemia Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prescription Drugs
Over-the-Counter (OTC)
Market segment by Application, can be divided into
Child
Adult
Elderly
Market segment by players, this report covers
AMAG Pharmaceuticals, Inc
Meda Consumer Healthcare Inc
American Regent, Inc
GSK
Avion Pharmaceuticals, LLC
Bausch Health Companies Inc
Colorado BiolabsInc
Prestige Consumer Healthcare Inc
Keryx Biopharmaceuticals, Inc
Daiichi Sankyo, Inc.
DSE Healthcare Solutions, LLC
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Iron Deficiency Anemia Drug
1.2 Classification of Iron Deficiency Anemia Drug by Type
1.2.1 Overview: Global Iron Deficiency Anemia Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Iron Deficiency Anemia Drug Revenue Market Share by Type in 2020
1.2.3 Prescription Drugs
1.2.4 Over-the-Counter (OTC)
1.3 Global Iron Deficiency Anemia Drug Market by Application
1.3.1 Overview: Global Iron Deficiency Anemia Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Child
1.3.3 Adult
1.3.4 Elderly
1.4 Global Iron Deficiency Anemia Drug Market Size & Forecast
1.5 Global Iron Deficiency Anemia Drug Market Size and Forecast by Region
1.5.1 Global Iron Deficiency Anemia Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Iron Deficiency Anemia Drug Market Size by Region, (2016-2021)
1.5.3 North America Iron Deficiency Anemia Drug Market Size and Prospect (2016-2026)
1.5.4 Europe Iron Deficiency Anemia Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Iron Deficiency Anemia Drug Market Size and Prospect (2016-2026)
1.5.6 South America Iron Deficiency Anemia Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Iron Deficiency Anemia Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Iron Deficiency Anemia Drug Market Drivers
1.6.2 Iron Deficiency Anemia Drug Market Restraints
1.6.3 Iron Deficiency Anemia Drug Trends Analysis
2 Company Profiles
2.1 AMAG Pharmaceuticals, Inc
2.1.1 AMAG Pharmaceuticals, Inc Details
2.1.2 AMAG Pharmaceuticals, Inc Major Business
2.1.3 AMAG Pharmaceuticals, Inc Iron Deficiency Anemia Drug Product and Solutions
2.1.4 AMAG Pharmaceuticals, Inc Iron Deficiency Anemia Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AMAG Pharmaceuticals, Inc Recent Developments and Future Plans
2.2 Meda Consumer Healthcare Inc
2.2.1 Meda Consumer Healthcare Inc Details
2.2.2 Meda Consumer Healthcare Inc Major Business
2.2.3 Meda Consumer Healthcare Inc Iron Deficiency Anemia Drug Product and Solutions
2.2.4 Meda Consumer Healthcare Inc Iron Deficiency Anemia Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Meda Consumer Healthcare Inc Recent Developments and Future Plans
2.3 American Regent, Inc
2.3.1 American Regent, Inc Details
2.3.2 American Regent, Inc Major Business
2.3.3 American Regent, Inc Iron Deficiency Anemia Drug Product and Solutions
2.3.4 American Regent, Inc Iron Deficiency Anemia Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 American Regent, Inc Recent Developments and Future Plans
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Iron Deficiency Anemia Drug Product and Solutions
2.4.4 GSK Iron Deficiency Anemia Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GSK Recent Developments and Future Plans
2.5 Avion Pharmaceuticals, LLC
2.5.1 Avion Pharmaceuticals, LLC Details
2.5.2 Avion Pharmaceuticals, LLC Major Business
2.5.3 Avion Pharmaceuticals, LLC Iron Deficiency Anemia Drug Product and Solutions
2.5.4 Avion Pharmaceuticals, LLC Iron Deficiency Anemia Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Avion Pharmaceuticals, LLC Recent Developments and Future Plans
2.6 Bausch Health Companies Inc
2.6.1 Bausch Health Companies Inc Details
2.6.2 Bausch Health Companies Inc Major Business
2.6.3 Bausch Health Companies Inc Iron Deficiency Anemia Drug Product and Solutions
2.6.4 Bausch Health Companies Inc Iron Deficiency Anemia Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bausch Health Companies Inc Recent Developments and Future Plans
2.7 Colorado BiolabsInc
2.7.1 Colorado BiolabsInc Details
2.7.2 Colorado BiolabsInc Major Business
2.7.3 Colorado BiolabsInc Iron Deficiency Anemia Drug Product and Solutions
2.7.4 Colorado BiolabsInc Iron Deficiency Anemia Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Colorado BiolabsInc Recent Developments and Future Plans
2.8 Prestige Consumer Healthcare Inc
2.8.1 Prestige Consumer Healthcare Inc Details
2.8.2 Prestige Consumer Healthcare Inc Major Business
2.8.3 Prestige Consumer Healthcare Inc Iron Deficiency Anemia Drug Product and Solutions
2.8.4 Prestige Consumer Healthcare Inc Iron Deficiency Anemia Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Prestige Consumer Healthcare Inc Recent Developments and Future Plans
2.9 Keryx Biopharmaceuticals, Inc
2.9.1 Keryx Biopharmaceuticals, Inc Details
2.9.2 Keryx Biopharmaceuticals, Inc Major Business
2.9.3 Keryx Biopharmaceuticals, Inc Iron Deficiency Anemia Drug Product and Solutions
2.9.4 Keryx Biopharmaceuticals, Inc Iron Deficiency Anemia Drug Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Keryx Biopharmaceuticals, Inc Recent Developments and Future Plans
2.10 Daiichi Sankyo, Inc.
2.10.1 Daiichi Sankyo, Inc. Details
2.10.2 Daiichi Sankyo, Inc. Major Business
2.10.3 Daiichi Sankyo, Inc. Iron Deficiency Anemia Drug Product and Solutions
2.10.4 Daiichi Sankyo, Inc. Iron Deficiency Anemia Drug Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Daiichi Sankyo, Inc. Recent Developments and Future Plans
2.11 DSE Healthcare Solutions, LLC
2.11.1 DSE Healthcare Solutions, LLC Details
2.11.2 DSE Healthcare Solutions, LLC Major Business
2.11.3 DSE Healthcare Solutions, LLC Iron Deficiency Anemia Drug Product and Solutions
2.11.4 DSE Healthcare Solutions, LLC Iron Deficiency Anemia Drug Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 DSE Healthcare Solutions, LLC Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Iron Deficiency Anemia Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Iron Deficiency Anemia Drug Players Market Share
3.2.2 Top 10 Iron Deficiency Anemia Drug Players Market Share
3.2.3 Market Competition Trend
3.3 Iron Deficiency Anemia Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Iron Deficiency Anemia Drug Revenue and Market Share by Type (2016-2021)
4.2 Global Iron Deficiency Anemia Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Iron Deficiency Anemia Drug Revenue Market Share by Application (2016-2021)
5.2 Iron Deficiency Anemia Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Iron Deficiency Anemia Drug Revenue by Type (2016-2026)
6.2 North America Iron Deficiency Anemia Drug Revenue by Application (2016-2026)
6.3 North America Iron Deficiency Anemia Drug Market Size by Country
6.3.1 North America Iron Deficiency Anemia Drug Revenue by Country (2016-2026)
6.3.2 United States Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
6.3.3 Canada Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Iron Deficiency Anemia Drug Revenue by Type (2016-2026)
7.2 Europe Iron Deficiency Anemia Drug Revenue by Application (2016-2026)
7.3 Europe Iron Deficiency Anemia Drug Market Size by Country
7.3.1 Europe Iron Deficiency Anemia Drug Revenue by Country (2016-2026)
7.3.2 Germany Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
7.3.3 France Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
7.3.5 Russia Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
7.3.6 Italy Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Iron Deficiency Anemia Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific Iron Deficiency Anemia Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific Iron Deficiency Anemia Drug Market Size by Region
8.3.1 Asia-Pacific Iron Deficiency Anemia Drug Revenue by Region (2016-2026)
8.3.2 China Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
8.3.3 Japan Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
8.3.5 India Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
8.3.7 Australia Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Iron Deficiency Anemia Drug Revenue by Type (2016-2026)
9.2 South America Iron Deficiency Anemia Drug Revenue by Application (2016-2026)
9.3 South America Iron Deficiency Anemia Drug Market Size by Country
9.3.1 South America Iron Deficiency Anemia Drug Revenue by Country (2016-2026)
9.3.2 Brazil Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Iron Deficiency Anemia Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa Iron Deficiency Anemia Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa Iron Deficiency Anemia Drug Market Size by Country
10.3.1 Middle East & Africa Iron Deficiency Anemia Drug Revenue by Country (2016-2026)
10.3.2 Turkey Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
10.3.4 UAE Iron Deficiency Anemia Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Iron Deficiency Anemia Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Iron Deficiency Anemia Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Iron Deficiency Anemia Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Iron Deficiency Anemia Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global Iron Deficiency Anemia Drug Revenue Market Share by Region (2021-2026)
Table 6. AMAG Pharmaceuticals, Inc Corporate Information, Head Office, and Major Competitors
Table 7. AMAG Pharmaceuticals, Inc Major Business
Table 8. AMAG Pharmaceuticals, Inc Iron Deficiency Anemia Drug Product and Solutions
Table 9. AMAG Pharmaceuticals, Inc Iron Deficiency Anemia Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Meda Consumer Healthcare Inc Corporate Information, Head Office, and Major Competitors
Table 11. Meda Consumer Healthcare Inc Major Business
Table 12. Meda Consumer Healthcare Inc Iron Deficiency Anemia Drug Product and Solutions
Table 13. Meda Consumer Healthcare Inc Iron Deficiency Anemia Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. American Regent, Inc Corporate Information, Head Office, and Major Competitors
Table 15. American Regent, Inc Major Business
Table 16. American Regent, Inc Iron Deficiency Anemia Drug Product and Solutions
Table 17. American Regent, Inc Iron Deficiency Anemia Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GSK Corporate Information, Head Office, and Major Competitors
Table 19. GSK Major Business
Table 20. GSK Iron Deficiency Anemia Drug Product and Solutions
Table 21. GSK Iron Deficiency Anemia Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Avion Pharmaceuticals, LLC Corporate Information, Head Office, and Major Competitors
Table 23. Avion Pharmaceuticals, LLC Major Business
Table 24. Avion Pharmaceuticals, LLC Iron Deficiency Anemia Drug Product and Solutions
Table 25. Avion Pharmaceuticals, LLC Iron Deficiency Anemia Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bausch Health Companies Inc Corporate Information, Head Office, and Major Competitors
Table 27. Bausch Health Companies Inc Major Business
Table 28. Bausch Health Companies Inc Iron Deficiency Anemia Drug Product and Solutions
Table 29. Bausch Health Companies Inc Iron Deficiency Anemia Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Colorado BiolabsInc Corporate Information, Head Office, and Major Competitors
Table 31. Colorado BiolabsInc Major Business
Table 32. Colorado BiolabsInc Iron Deficiency Anemia Drug Product and Solutions
Table 33. Colorado BiolabsInc Iron Deficiency Anemia Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Prestige Consumer Healthcare Inc Corporate Information, Head Office, and Major Competitors
Table 35. Prestige Consumer Healthcare Inc Major Business
Table 36. Prestige Consumer Healthcare Inc Iron Deficiency Anemia Drug Product and Solutions
Table 37. Prestige Consumer Healthcare Inc Iron Deficiency Anemia Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Keryx Biopharmaceuticals, Inc Corporate Information, Head Office, and Major Competitors
Table 39. Keryx Biopharmaceuticals, Inc Major Business
Table 40. Keryx Biopharmaceuticals, Inc Iron Deficiency Anemia Drug Product and Solutions
Table 41. Keryx Biopharmaceuticals, Inc Iron Deficiency Anemia Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Daiichi Sankyo, Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Daiichi Sankyo, Inc. Major Business
Table 44. Daiichi Sankyo, Inc. Iron Deficiency Anemia Drug Product and Solutions
Table 45. Daiichi Sankyo, Inc. Iron Deficiency Anemia Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. DSE Healthcare Solutions, LLC Corporate Information, Head Office, and Major Competitors
Table 47. DSE Healthcare Solutions, LLC Major Business
Table 48. DSE Healthcare Solutions, LLC Iron Deficiency Anemia Drug Product and Solutions
Table 49. DSE Healthcare Solutions, LLC Iron Deficiency Anemia Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Iron Deficiency Anemia Drug Revenue (USD Million) by Players (2019-2021)
Table 51. Global Iron Deficiency Anemia Drug Revenue Share by Players (2019-2021)
Table 52. Breakdown of Iron Deficiency Anemia Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Iron Deficiency Anemia Drug Players Head Office, Products and Services Provided
Table 54. Iron Deficiency Anemia Drug Mergers & Acquisitions in the Past Five Years
Table 55. Iron Deficiency Anemia Drug New Entrants and Expansion Plans
Table 56. Global Iron Deficiency Anemia Drug Revenue (USD Million) by Type (2016-2021)
Table 57. Global Iron Deficiency Anemia Drug Revenue Share by Type (2016-2021)
Table 58. Global Iron Deficiency Anemia Drug Revenue Forecast by Type (2021-2026)
Table 59. Global Iron Deficiency Anemia Drug Revenue by Application (2016-2021)
Table 60. Global Iron Deficiency Anemia Drug Revenue Forecast by Application (2021-2026)
Table 61. North America Iron Deficiency Anemia Drug Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Iron Deficiency Anemia Drug Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Iron Deficiency Anemia Drug Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Iron Deficiency Anemia Drug Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Iron Deficiency Anemia Drug Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Iron Deficiency Anemia Drug Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Iron Deficiency Anemia Drug Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Iron Deficiency Anemia Drug Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Iron Deficiency Anemia Drug Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Iron Deficiency Anemia Drug Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Iron Deficiency Anemia Drug Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Iron Deficiency Anemia Drug Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Iron Deficiency Anemia Drug Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Iron Deficiency Anemia Drug Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Iron Deficiency Anemia Drug Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Iron Deficiency Anemia Drug Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Iron Deficiency Anemia Drug Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Iron Deficiency Anemia Drug Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Iron Deficiency Anemia Drug Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Iron Deficiency Anemia Drug Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Iron Deficiency Anemia Drug Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Iron Deficiency Anemia Drug Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Iron Deficiency Anemia Drug Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Iron Deficiency Anemia Drug Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Iron Deficiency Anemia Drug Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Iron Deficiency Anemia Drug Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Iron Deficiency Anemia Drug Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Iron Deficiency Anemia Drug Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Iron Deficiency Anemia Drug Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Iron Deficiency Anemia Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Iron Deficiency Anemia Drug Picture
Figure 2. Global Iron Deficiency Anemia Drug Revenue Market Share by Type in 2020
Figure 3. Prescription Drugs
Figure 4. Over-the-Counter (OTC)
Figure 5. Iron Deficiency Anemia Drug Revenue Market Share by Application in 2020
Figure 6. Child Picture
Figure 7. Adult Picture
Figure 8. Elderly Picture
Figure 9. Global Iron Deficiency Anemia Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Iron Deficiency Anemia Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Iron Deficiency Anemia Drug Revenue Market Share by Region (2016-2026)
Figure 12. Global Iron Deficiency Anemia Drug Revenue Market Share by Region in 2020
Figure 13. North America Iron Deficiency Anemia Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Iron Deficiency Anemia Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Iron Deficiency Anemia Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Iron Deficiency Anemia Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Iron Deficiency Anemia Drug Market Drivers
Figure 18. Iron Deficiency Anemia Drug Market Restraints
Figure 19. Iron Deficiency Anemia Drug Market Trends
Figure 20. AMAG Pharmaceuticals, Inc Recent Developments and Future Plans
Figure 21. Meda Consumer Healthcare Inc Recent Developments and Future Plans
Figure 22. American Regent, Inc Recent Developments and Future Plans
Figure 23. GSK Recent Developments and Future Plans
Figure 24. Avion Pharmaceuticals, LLC Recent Developments and Future Plans
Figure 25. Bausch Health Companies Inc Recent Developments and Future Plans
Figure 26. Colorado BiolabsInc Recent Developments and Future Plans
Figure 27. Prestige Consumer Healthcare Inc Recent Developments and Future Plans
Figure 28. Keryx Biopharmaceuticals, Inc Recent Developments and Future Plans
Figure 29. Daiichi Sankyo, Inc. Recent Developments and Future Plans
Figure 30. DSE Healthcare Solutions, LLC Recent Developments and Future Plans
Figure 32. Global Iron Deficiency Anemia Drug Revenue Share by Players in 2020
Figure 33. Iron Deficiency Anemia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Iron Deficiency Anemia Drug Revenue Market Share in 2020
Figure 35. Global Top 10 Players Iron Deficiency Anemia Drug Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Iron Deficiency Anemia Drug Revenue Share by Type in 2020
Figure 38. Global Iron Deficiency Anemia Drug Market Share Forecast by Type (2021-2026)
Figure 39. Global Iron Deficiency Anemia Drug Revenue Share by Application in 2020
Figure 40. Global Iron Deficiency Anemia Drug Market Share Forecast by Application (2021-2026)
Figure 41. North America Iron Deficiency Anemia Drug Sales Market Share by Type (2016-2026)
Figure 42. North America Iron Deficiency Anemia Drug Sales Market Share by Application (2016-2026)
Figure 43. North America Iron Deficiency Anemia Drug Revenue Market Share by Country (2016-2026)
Figure 44. United States Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Iron Deficiency Anemia Drug Sales Market Share by Type (2016-2026)
Figure 48. Europe Iron Deficiency Anemia Drug Sales Market Share by Application (2016-2026)
Figure 49. Europe Iron Deficiency Anemia Drug Revenue Market Share by Country (2016-2026)
Figure 50. Germany Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Iron Deficiency Anemia Drug Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Iron Deficiency Anemia Drug Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Iron Deficiency Anemia Drug Revenue Market Share by Region (2016-2026)
Figure 58. China Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Iron Deficiency Anemia Drug Sales Market Share by Type (2016-2026)
Figure 65. South America Iron Deficiency Anemia Drug Sales Market Share by Application (2016-2026)
Figure 66. South America Iron Deficiency Anemia Drug Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Iron Deficiency Anemia Drug Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Iron Deficiency Anemia Drug Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Iron Deficiency Anemia Drug Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Iron Deficiency Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の鉄欠乏性貧血療法市場規模・現状・予測（2021年-2027年） Iron deficiency anemia is anemia that occurs when iron stores cannot meet the needs of normal red blood cell production.This is due to insufficient iron intake, reduced absorption, increased demand, and excess iron deficiency or loss.The morphology is small cell hypochromic anemia.Iron deficiency an…- 世界の貧血治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anemia Drugs Market The global Anemia Drugs market size is projected to reach US$ 15910 million by 2026, from US$ 11620 million in 2019, at a CAGR of 4.5% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a br…
- 世界の貧血治療市場規模・現状・予測（2021年-2027年） Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia. The iron deficiency anemia market segment accounted for the…
- 世界の貧血治療市場規模・現状・予測（2021年-2027年） Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia. The iron deficiency anemia market segment accounted for the…
- 世界のチロシンヒドロキシラーゼ欠損症治療薬市場規模・現状・予測（2021年-2027年） The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…